138 related articles for article (PubMed ID: 12124691)
1. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation.
Chen M; Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
Prenat Diagn; 2002 Jul; 22(7):576-8. PubMed ID: 12124691
[TBL] [Abstract][Full Text] [Related]
2. Influence of ethnic origin on nuchal translucency screening for Down's syndrome.
Thilaganathan B; Khare M; Williams B; Wathen NC
Ultrasound Obstet Gynecol; 1998 Aug; 12(2):112-4. PubMed ID: 9744055
[TBL] [Abstract][Full Text] [Related]
3. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations.
Spencer K; Heath V; El-Sheikhah A; Ong CY; Nicolaides KH
Prenat Diagn; 2005 May; 25(5):365-9. PubMed ID: 15906426
[TBL] [Abstract][Full Text] [Related]
4. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
5. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation.
Lam YH; Tang MH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF
Prenat Diagn; 2001 Aug; 21(8):627-9. PubMed ID: 11536259
[TBL] [Abstract][Full Text] [Related]
6. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
7. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
8. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
Crossley JA; Aitken DA; Cameron AD; McBride E; Connor JM
BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646
[TBL] [Abstract][Full Text] [Related]
9. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.
Cheng CC; Bahado-Singh RO; Chen SC; Tsai MS
Int J Gynaecol Obstet; 2004 Jan; 84(1):5-9. PubMed ID: 14698823
[TBL] [Abstract][Full Text] [Related]
11. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
12. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
13. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K; Bindra R; Nix AB; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):142-8. PubMed ID: 12905507
[TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
15. The relationship between maternal body mass, smoking status and ethnicity and first trimester nuchal translucency thickness.
Cowans NJ; Spencer K
Prenat Diagn; 2011 May; 31(5):446-9. PubMed ID: 21351280
[TBL] [Abstract][Full Text] [Related]
16. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
17. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
18. Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening.
Logghe H; Cuckle H; Sehmi I
Prenat Diagn; 2003 May; 23(5):389-92. PubMed ID: 12749036
[TBL] [Abstract][Full Text] [Related]
19. Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis.
Borruto F; Comparetto C; Acanfora L; Bertini G; Rubaltelli FF
Clin Exp Obstet Gynecol; 2002; 29(4):235-41. PubMed ID: 12635737
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nuchal translucency measurement and second-trimester triple serum screening in twin versus singleton pregnancies.
Maymon R; Dreazen E; Rozinsky S; Bukovsky I; Weinraub Z; Herman A
Prenat Diagn; 1999 Aug; 19(8):727-31. PubMed ID: 10451516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
